These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31948346)

  • 21. Drug-drug interactions of cytostatics with regular medicines in lung cancer patients.
    Rompelman FM; Smit AA; Franssen EJ; Crul M
    J Oncol Pharm Pract; 2017 Oct; 23(7):483-490. PubMed ID: 27530243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Drug Wastage and Mitigation Methods: A Systematic Review.
    Rajangom KS; Erenay FS; He QM; Figueiredo R; Chan KKW; Cheung MC; Charbonneau LF; Horton SE; Denburg A
    Value Health; 2024 Sep; ():. PubMed ID: 39343092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the intravenous narcotics and controlled drugs wastage and their financial impact: A descriptive single-center study.
    Ishaqui AA; Al Qahtani A; Ashraful Islam M; Al Dossary I; Maqsood MB; Al Dulaijan A; Al Jowesim F; Alshammari ASS; Mahdi AlShayban D; Alsultan MT; Azizullah Ghori S; Khan SU; Yamin F; Shahid Iqbal M
    Saudi Pharm J; 2023 Mar; 31(3):329-334. PubMed ID: 37026053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying Drug Wastage and Economic Loss of Chemotherapy Drugs at an Adult Oncology Care of a Tertiary Care Public Hospital in India.
    Fulsoundar R; Kadhe N; Patil S; Ghate S; Pawar S
    Cureus; 2023 Nov; 15(11):e49242. PubMed ID: 38143662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-assisted management of unconsumed drugs as a cost-containment strategy in oncology.
    Respaud R; Tournamille JF; Saintenoy G; Linassier C; Elfakir C; Viaud-Massuard MC; Antier D
    Int J Clin Pharm; 2014 Oct; 36(5):892-5. PubMed ID: 25022715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medications collected for disposal by outreach pharmacists in Australia.
    Guirguis K
    Pharm World Sci; 2010 Feb; 32(1):52-8. PubMed ID: 19823939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What are the expectations of coordination and accompaniment of French patients with cancer towards their community pharmacist?].
    Hébert G; Minvielle E; Di Palma M; Lemare F
    Bull Cancer; 2018 Mar; 105(3):245-255. PubMed ID: 29486920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center.
    Solomon JM; Ajewole VB; Schneider AM; Sharma M; Bernicker EH
    J Oncol Pharm Pract; 2019 Oct; 25(7):1564-1569. PubMed ID: 30170514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Wastage and Economic Effects of Anaesthetic Drugs and Consumables in the Operating Room.
    Peker K
    Turk J Anaesthesiol Reanim; 2020 Aug; 48(4):321-327. PubMed ID: 32864648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral cytotoxic drug wastage at a tertiary hospital in Kuala Lumpur: How much and why?
    Ang ZY; Cheah KY; Abdullah NB; Samsuri SB; Lee SH; Yem AW; Sriraman MA
    J Oncol Pharm Pract; 2020 Sep; 26(6):1306-1317. PubMed ID: 31810422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The status of drug wastage in the pediatric emergency department of a tertiary hospital.
    Bucak IH; Almis H; Dogan CN; Turgut M
    Avicenna J Med; 2020; 10(1):10-14. PubMed ID: 32110544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating a pharmacist into an anaesthesiology and critical care department: Is this worthwhile?
    Chapuis C; Albaladejo P; Billon L; Catoire C; Chanoine S; Allenet B; Bouzat P; Bedouch P; Payen JF
    Int J Clin Pharm; 2019 Dec; 41(6):1491-1498. PubMed ID: 31595449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Kearns B; Pandor A; Stevenson M; Hamilton J; Chambers D; Clowes M; Graham J; Kumar MS
    Pharmacoeconomics; 2017 Apr; 35(4):415-424. PubMed ID: 27770303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
    de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
    J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug waste minimization as an effective strategy of cost-containment in oncology.
    Fasola G; Aprile G; Marini L; Follador A; Mansutti M; Miscoria M
    BMC Health Serv Res; 2014 Feb; 14():57. PubMed ID: 24507545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interactions with oral antineoplastic drugs: The role of the pharmacist.
    Riu-Viladoms G; Carcelero San Martín E; Martín-Conde MT; Creus N
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12944. PubMed ID: 30324634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.